BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29845720)

  • 41. Amphipathic sulfonamidobenzamides mimicking small antimicrobial marine natural products; investigation of antibacterial and anti-biofilm activity against antibiotic resistant clinical isolates.
    Igumnova EM; Mishchenko E; Haug T; Blencke HM; Sollid JUE; Fredheim EGA; Lauksund S; Stensvåg K; Strøm MB
    Bioorg Med Chem; 2018 Sep; 26(17):4930-4941. PubMed ID: 30185388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of MRSA active antibiotics using primary sequence from the human microbiome.
    Chu J; Vila-Farres X; Inoyama D; Ternei M; Cohen LJ; Gordon EA; Reddy BV; Charlop-Powers Z; Zebroski HA; Gallardo-Macias R; Jaskowski M; Satish S; Park S; Perlin DS; Freundlich JS; Brady SF
    Nat Chem Biol; 2016 Dec; 12(12):1004-1006. PubMed ID: 27748750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial activity of pyrrolopyridine-substituted oxazolidinones: synthesis and in vitro SAR of various C-5 acetamide replacements.
    Paget SD; Boggs CM; Foleno BD; Goldschmidt RM; Hlasta DJ; Weidner-Wells MA; Werblood HM; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4537-42. PubMed ID: 16806921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria.
    Liu J; He B; Yu A; Zhou W
    Chem Biol Drug Des; 2007 Apr; 69(4):265-8. PubMed ID: 17461974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.
    Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6175-8. PubMed ID: 18947996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
    Kaushik A; Heuer AM; Bell DT; Culhane JC; Ebner DC; Parrish N; Ippoliti JT; Lamichhane G
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3572-6. PubMed ID: 27329794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping of the modular closthioamide architecture reveals crucial motifs of polythioamide antibiotics.
    Kloss F; Chiriac AI; Hertweck C
    Chemistry; 2014 Nov; 20(47):15451-8. PubMed ID: 25284750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent development of potent analogues of oxazolidinone antibacterial agents.
    Michalska K; Karpiuk I; Król M; Tyski S
    Bioorg Med Chem; 2013 Feb; 21(3):577-91. PubMed ID: 23273607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties.
    Kim SY; Park HB; Cho JH; Yoo KH; Oh CH
    Bioorg Med Chem Lett; 2009 May; 19(9):2558-61. PubMed ID: 19345578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity.
    Spaulding A; Takrouri K; Mahalingam P; Cleary DC; Cooper HD; Zucchi P; Tear W; Koleva B; Beuning PJ; Hirsch EB; Aggen JB
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5310-5321. PubMed ID: 29102393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antibacterial activities of new piperidine substituted (5R)-[1,2,3]triazolylmethyl and (5R)-[(4-F-[1,2,3]triazolyl)methyl] oxazolidinones.
    Shin HN; Seo SH; Choo H; Kuem G; Choi KI; Nam G
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1193-6. PubMed ID: 23385213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials.
    Komine T; Kojima A; Asahina Y; Saito T; Takano H; Shibue T; Fukuda Y
    J Med Chem; 2008 Oct; 51(20):6558-62. PubMed ID: 18826297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel Mannich ketones of oxazolidinones as antibacterial agents.
    Srivastava BK; Kapadnis PB; Pandya P; Lohray VB
    Eur J Med Chem; 2004 Nov; 39(11):989-92. PubMed ID: 15501548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and preliminary antibacterial evaluation of Linezolid-like 1,2,4-oxadiazole derivatives.
    Palumbo Piccionello A; Musumeci R; Cocuzza C; Fortuna CG; Guarcello A; Pierro P; Pace A
    Eur J Med Chem; 2012 Apr; 50():441-8. PubMed ID: 22365410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of conformationally constrained analogues of linezolid: structure-activity relationship (SAR) studies on selected novel tricyclic oxazolidinones.
    Selvakumar N; Srinivas D; Khera MK; Kumar MS; Mamidi RN; Sarnaik H; Charavaryamath C; Rao BS; Raheem MA; Das J; Iqbal J; Rajagopalan R
    J Med Chem; 2002 Aug; 45(18):3953-62. PubMed ID: 12190317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones.
    Srivastava BK; Soni R; Patel JZ; Solanki M; Valani D; Gupta S; Mishra B; Takale V; Pandya P; Jain MR; Patel PR
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5227-32. PubMed ID: 17624776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)}-phenyl] -ethyl]-piperazin-1-yl}-fluoroquinolones].
    Yu HJ; Zhou WC
    Yao Xue Xue Bao; 2006 Oct; 41(10):990-9. PubMed ID: 17184119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
    Takhi M; Murugan C; Munikumar M; Bhaskarreddy KM; Singh G; Sreenivas K; Sitaramkumar M; Selvakumar N; Das J; Trehan S; Iqbal J
    Bioorg Med Chem Lett; 2006 May; 16(9):2391-5. PubMed ID: 16488606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological evaluation of the ascidian blood-pigment halocyamine A.
    Fong HKH; Brunel JM; Longeon A; Bourguet-Kondracki ML; Barker D; Copp BR
    Org Biomol Chem; 2017 Jul; 15(29):6194-6204. PubMed ID: 28695949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.